Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    Why did this record match?
    Reference Devices :

    K241518, K232235

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    For Adults: Horizon 3.0 TMS Therapy Systems are indicated for the treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode, as well as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).

    For Adolescents: Horizon 3.0 TMS Therapy Systems are indicated as an adjunct for the treatment of MDD in adolescent patients (age 15-21).

    Device Description

    The Horizon® 3.0 TMS Therapy System is a computerized, electromechanical medical device that produces and delivers non-invasive, magnetic stimulation rapidly alternating, or pulsed, magnetic fields to induce electrical currents directed at spatially discrete regions of the cerebral cortex. This method of cortical stimulation by application of brief magnetic pulses to the head is known as Transcranial Magnetic Stimulation. ("TMS").

    The Horizon® 3.0 TMS Therapy System is a non-invasive tool for the stimulation of cortical neurons for the treatment of

    • Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode
    • as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
    • as an adjunct for the treatment of Major Depressive Disorder in adolescent patients (age 15--21)

    The Horizon® 3.0 TMS Therapy System is used for patient treatment by prescription only under the supervision of a licensed physician. It can be used in both inpatient settings, including physicians' offices, clinics, and hospitals.

    The Horizon® 3.0 TMS Therapy System configurations are an integrated system consisting of a combination of hardware, software, and accessories.

    The Horizon® 3.0 TMS Therapy System is offered in three configurations:

    The three tiers of system offer equivalent safety and effectiveness with the main purpose allowing for physician offices, clinics and hospitals to choose a configuration that suits the organizational needs and provide different entry levels to promote the accessibility of TMS Therapy Treatments to health delivery organizations.

    All three configurations have identical intended use/indications for use, common specifications, equivalent performance and equivalent composition. All three devices share equivalent technological characteristics and principles of operation.

    All configurations are composed from the following main components:

    • Stimulating Unit & Power Supply -
    • User Interface
    • Applicating Coil for Motor Threshold -
    • -Applicating Coil for Treatment Delivery
    • -System and Applicating Coil Cart and Holding Arm

    The Horizon 3.0 with StimGuide Pro specifically includes a stereotactic infrared tracking system for aiding coil positioning.

    AI/ML Overview

    Below is a summary of the acceptance criteria and the study that proves the device meets the criteria.

    1. Table of Acceptance Criteria and Reported Device Performance

    Test CategoryAcceptance Criteria (Implied)Reported Device Performance
    Electromagnetic Compatibility (EMC)Compliance with IEC 60601-1-2. Demonstrated equivalent EMC level to the primary predicate device.The Horizon 3.0 TMS Therapy System was tested and found compliant with IEC 60601-1-2, demonstrating an equivalent level of EMC as the primary predicate device.
    Electrical & Mechanical SafetyCompliance with IEC 60601-1 (including IEC 60601-1-6 and IEC 60601-1-8). Demonstrated equivalent electrical and mechanical safety level to the primary predicate device.The Horizon 3.0 TMS Therapy System was tested and found compliant with IEC 60601-1 standards, demonstrating an equivalent level of electrical and mechanical safety as the primary predicate device.
    Thermal SafetyCompliance with IEC 60601-1 (including IEC 60601-1-6 and IEC 60601-1-8). Ability of Horizon Air Film Coil and Horizon 3.0 Ez Cool Coil to execute OCD, iTBS, and rTMS protocols at worst-case ambient conditions without excessive temperatures.The system was compliant with IEC 60601-1. Additional testing confirmed the Horizon Air Film Coil and Horizon 3.0 Ez Cool Coil could perform protocols safely and effectively, even at worst-case ambient conditions (80%-100% output, 30°C), comparable to the predicate.
    Software Verification & ValidationAppropriate function of software, demonstrating it cannot contribute to any unacceptable risk (following IEC 62304 and FDA Software Guidance). Software behavior is consistent and compatible across all configurations and fulfills its intended use, with cybersecurity tested to ensure security equivalent to the primary predicate.Software development followed IEC 62304. Lifecycle documentation demonstrated appropriate function and no unacceptable risk. Software behavior was consistent, compatible, and passed cybersecurity testing, ensuring security equivalent to the primary predicate.
    Usability/Human Factors EngineeringAppropriate human factors and usability for intended use, free from unacceptable use-related risks (following IEC 60601-1-6, IEC 62366-1, ANSI/AAMI HE75). Consistency of workflows, UIs, and components promoting a healthy usability profile.Human factors evaluation demonstrated appropriate usability and freedom from unacceptable use-related risks. Consistency across configurations promotes a healthy usability profile.
    Magnetic Pulse Output & Field TestingEquivalence of electric field distribution, power outputs, magnetic fields, field spatial distribution, E-field decay, output waveforms, magnetic field strength, and rate of change between subject coils (Ez Cool Coil, Air Film Coil) and predicate coil (Neuronetics Coil) at clinically relevant depths (2-3cm). Compliance with Special Controls: 21 C.F.R. § 882.5802, 21 C.F.R. § 882.5805, and FDA Guidance "Repetitive Transcranial Magnetic Stimulation (rTMS) Systems."Measurements in a phantom head model showed equivalent power outputs, electric and magnetic fields, and key field characteristics between the subject and predicate coils at clinically relevant depths (2-3cm).
    Safety Feature TestingMaintenance of appropriate safety features, exercising many fault scenarios, and ensuring interlocks with respect to safety features (following IEC 60601-1). Testing includes introducing failure modes to test multiple fault conditions (e.g., disabling software check and ensuring hardware backup interlock is active).All fault scenarios and safety features were tested and complied with IEC 60601-1, demonstrating substantial equivalence of safety features among all device configurations.
    Acoustic TestingSystem does not reach excessive/unacceptable noise levels under simulated use scenarios with Horizon Air Film Coil and Horizon 3.0 Ez Cool Coil (following IEC 60601-1).Acoustic testing under simulated use scenarios (maximum machine output for recommended protocols) demonstrated the system with the specified coils does not reach excessive/unacceptable noise levels.

    2. Sample Size Used for the Test Set and Data Provenance

    The summary details a series of non-clinical tests. These tests primarily involve physical measurements and simulations, rather than collecting data from human subjects.

    • Sample Size for Test Set: Not applicable in the traditional sense of human subjects. For the magnetic and electrical field testing, the "test set" was the physical setup involving a phantom head model and specific coils. No numerical sample size for patients is provided.
    • Data Provenance: The data comes from in-house engineering and laboratory testing performed by The Magstim Company Limited, in accordance with international standards. This is not retrospective or prospective clinical data from human patients, but rather performance data generated from the device itself and its components. The country of origin for the testing is implicitly the United Kingdom, where the applicant is located.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

    Given the nature of the non-clinical tests described, the concept of "experts establishing ground truth" for a test set in a human clinical context is not directly applicable.

    • Magnetic and Electrical Field Testing: This testing involved physical measurements using a phantom head model and measuring probes. The "ground truth" here is the physical output of the device under controlled conditions, measured against established scientific principles and comparison to a legally marketed predicate device. The expertise involved would be in engineering, physics, and medical device testing, ensuring the test setup, execution, and interpretation of results are scientifically sound and comply with regulatory guidance.
    • Other Non-Clinical Tests: For areas like Electrical, Mechanical, Thermal Safety, EMC, Software V&V, Usability, Safety Features, and Acoustic Testing, compliance is determined by adherence to specific international standards (e.g., IEC 60601 series, IEC 62304, ISO 10993, AAMI/ANSI HE75) and FDA guidance documents. The "ground truth" is defined by these standards and the expertise lies with the engineers and quality assurance personnel who conduct these tests and verify compliance.

    No specific number or qualifications of "experts" are provided in the summary, as this is typically inherent in the regulatory-compliant testing process conducted by the manufacturer.

    4. Adjudication Method for the Test Set

    Not applicable. Adjudication methods like 2+1 or 3+1 are typically used in clinical studies involving interpretation of medical images or patient outcomes, where ambiguous cases require expert consensus. The tests described here are non-clinical, objective measurements and compliance checks against established standards.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC comparative effectiveness study was not done. The summary explicitly states: "Clinical Testing - Not Applicable." The submission relies solely on non-clinical testing to demonstrate substantial equivalence.

    6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done

    This question is not entirely applicable as the device in question (Horizon 3.0 TMS Therapy System) is a hardware-based medical device that delivers magnetic stimulation. While it contains software, it is not an AI algorithm that generates diagnostic outputs or interpretations that would typically have a "standalone" performance metric in the absence of human input or a human-in-the-loop. The software functions to control the hardware and deliver therapy protocols, and its performance is validated as part of the overall device system.

    7. The Type of Ground Truth Used

    The ground truth used for these non-clinical tests is primarily based on:

    • Compliance with International Standards: The device's performance is measured against established safety, EMC, thermal, electrical, mechanical, and software standards (e.g., IEC 60601 series, IEC 62304).
    • Scientific Principles and Physical Measurements: For magnetic and electrical field testing, the ground truth is derived from quantitative physical measurements conducted in a controlled phantom head model according to scientific principles.
    • Comparison to a Legally Marketed Predicate Device: Substantial equivalence is established by demonstrating that the subject device's performance characteristics (e.g., magnetic field output, treatment protocols) are equivalent to those of the predicate device (NeuroStar Advanced Therapy System) and previously cleared Magstim devices.

    There is no pathology, expert consensus (in a diagnostic sense), or outcomes data from human patients used as ground truth in this submission, as it focuses on non-clinical performance.

    8. The Sample Size for the Training Set

    Not applicable. This device is a medical device for therapy, not a machine learning model that requires a distinct "training set" of data in the AI sense. The software embedded in the device is developed and validated through traditional software engineering practices (IEC 62304), not through machine learning training on a dataset.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable, as there is no machine learning "training set" for this device. The software development and validation followed established engineering principles and regulatory standards (IEC 62304), which ensure the software functions as intended and meets safety requirements.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1